Asthma Therapeutics Market
Asthma Therapeutics Market Size, Share & Trends Analysis Report Forecasts By Product Type (Inhalation, Parenteral And Oral) And By End-User (Hospitals, Clinics And Others) Based On Region, And Segment Forecasts, 2022- 2028
Global Asthma Therapeutics Market 2019-2025: The forecast period 2018-2024 is expected to show noticeable growth in global Asthma Therapeutics Market. There will be a new resurgence in the sales and utilisation of Asthma Therapeutics. Are you ready to cope up with growing market? No, then have a look at our report overview and send your query to us.
Asthma is a long term & chronic inflammatory disease and it affects more than 500 million people worldwide. It represents 2 most prevalent inflammatory diseases. It is characterised by bronchospasm and reversible airflow obstruction and symptoms are like coughing, wheezing, shortness of breath and chest tightness.
Our report studies global Asthma Therapeutics market and covers historical and forecast data for application, regional and country.
This Global Asthma Therapeutics Market Report Covers Top Players:
- AstraZeneca plc
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Chiesi Farmaceutici S.p.A.
- Cipla Ltd.
- Genentech, Inc.
- GlaxoSmithKline plc
- Johnson & Johnson
- Merck & Co., Inc.
- Mundipharma International Limited
- Mylan N.V.
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
- Roche Holding AG
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Theravance Biopharma, Inc.
- Vectura Group plc
- Others
Along with these leading players, there are number of other small and mid-sized players who are coming with huge investment and innovative product launch in the Artificial Organs industry.
We have segmented global Asthma Therapeutics Market as follows,
By Drug Class
- Anti-Inflammatory
- Bronchodilators
- Combination Therapy
- Leukotriene Antagonists
- Mast Cell Stabilizers
- Immunosuppressants
By Product
- Inhalers
- Soft Mist Inhalers
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nebulizers
By Route of Administration
- Oral
- Inhaled
- Others
By End-user
- Hospitals and Clinics
- Homecare
- Others
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
On Special Requirement Asthma Market Report is also available for the below Regions and Countries:
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherland
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest Of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest Of MEA
|
Report Analysis |
Details |
|
Historical data |
2018 - 2021 |
|
Forecast Period |
2022 - 2028 |
|
Market Size in 2021: |
XX |
|
Base year considered |
2021 |
|
Forecast Period CAGR %: |
XX |
|
Market Size Expected in 2028: |
XX |
|
Tables, Charts & Figures: |
175 |
|
Pages |
200 |
|
Companies/Key Players |
AstraZeneca plc. Boehringer Ingelheim Pharmaceuticals, Inc., Chiesi Farmaceutici S.p.A., Cipla Ltd., Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Mundipharma International Limited, Mylan N.V., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Roche Holding AG, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva , harmaceutical Industries Ltd., Theravance Biopharma, Inc., Vectura Group plc, Others. |
|
Segments Covered |
By Product ,By End-user |
|
Regional Analysis |
North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa |
Key Benefits for Asthma Therapeutics market reports:-
- Global Asthma Therapeutics market report covers in-depth historical and forecast analysis.
- Global Asthma Therapeutics Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Asthma Therapeutics market report helps to identify opportunities in the marketplace.
- Global Asthma Therapeutics market report covers extensive analysis of emerging trends and the competitive landscape.
Segments
By Drug Class
- Anti-Inflammatory
- Bronchodilators
- Combination Therapy
- Leukotriene Antagonists
- Mast Cell Stabilizers
- Immunosuppressants
By Product
- Inhalers
- Soft Mist Inhalers
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nebulizers
By Route of Administration
- Oral
- Inhaled
- Others
By End-user
- Hospitals and Clinics
- Homecare
- Others
By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
- AstraZeneca plc
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Chiesi Farmaceutici S.p.A.
- Cipla Ltd.
- Genentech, Inc.
- GlaxoSmithKline plc
- Johnson & Johnson
- Merck & Co., Inc.
- Mundipharma International Limited
- Mylan N.V.
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals, Inc.
- Roche Holding AG
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Theravance Biopharma, Inc.
- Vectura Group plc
- Others